uottawa Tag

17 Sep

Posted at 12:17h in Addiction, Public Health

Addiction Notice: If you or someone you know needs help with substance use, contact SAMHSA at 1-800-662-4357 (free, confidential, 24/7) or visit findtreatment.gov. Do not stop using substances abruptly without medical supervision, as withdrawal can be life-threatening.

MedicalResearch.com Interview with:

Adrienne Gaudreault, MPH Medical Student, Dalhousie University

[caption id="attachment_76058" align="alignleft" width="125"] Dr. Daniel Myran[/caption]

Daniel T. Myran, MD, MPH, CCFP, FRCPC Public Health and Preventive Medicine Ottawa Hospital Research Institute; Canada Research Chair University of Ottawa Department of Family Medicine

See the Video version of this interview

04 Mar

Posted at 00:46h in Addiction, CMAJ
[caption id="attachment_72632" align="aligncenter" width="500"]online-gambling-young-men.jpg Photo by Niek Doup on Unsplash[/caption] MedicalResearch.com Interview with: [caption id="attachment_72636" align="alignleft" width="200"]Ryan ForrestPublic health doctoral student Dalla Lana School of Public Health University of Toronto Ryan Forrest[/caption] Ryan Forrest Public health doctoral student Dalla Lana School of Public Health University of Toronto MedicalResearch.com: What is the background for this study? Response: Over the past decade, there have been major changes to the gambling landscape across North America, including how accessible gambling is, what products are available, and how aggressively gambling is marketed and promoted. Our study focused on Ontario, where several key policy changes created a natural opportunity to examine potential health impacts. Online gambling was introduced through a government-run platform in 2015. In 2021, federal legislation legalized single-event sports betting, enabling new gambling formats. Then, in April 2022, Ontario became the first and only jurisdiction in Canada to open a competitive private online gambling market, allowing private companies,  including some large multinational operators, to offer and heavily advertise gambling products. Many Ontarians experienced a rapid increase in gambling advertising and visibility following this shift. To understand whether these changes were associated with health harms, we examined contacts to ConnexOntario, the province’s mental health and addictions helpline, for gambling-related problems.

07 Jan

Posted at 16:43h in Author Interviews, Cannabis, JAMA, Pediatrics
MedicalResearch.com Interview with: [caption id="attachment_58615" align="alignleft" width="150"]Daniel Myran, MD, MPH, CCFP, FRCPC Family and Public Health and Preventive Medicine Physician  CIHR Fellow, Ottawa Hospital Research Institute  Department of Family Medicine Innovation Fellow University of Ottawa  Dr. Myran[/caption] Daniel Myran, MD, MPH, CCFP, FRCPC Family and Public Health and Preventive Medicine Physician CIHR Fellow, Ottawa Hospital Research Institute Department of Family Medicine Innovation Fellow University of Ottawa MedicalResearch.com: What is the background for this study? Response: Canada legalized recreational, or non-medical, cannabis in October 2018. Canada took phased approach to legalization initially only allowing flower-based cannabis products and oils and after one year permitting the sale of commercial cannabis edibles (e.g. THC containing candies, baked goods, and drinks). In this study we took advantage of this phased roll out of legal cannabis to understand the impact of legalization on cannabis exposures or poisonings in children aged 0-9 years and the contribution of different types of cannabis products to these events.

09 Jun

Posted at 00:37h in Author Interviews, Clots - Coagulation, JAMA, Kidney Disease
MedicalResearch.com Interview with: [caption id="attachment_54478" align="alignleft" width="133"]Manish M Sood MD FRCPC MSc Jindal Research Chair for the Prevention of Kidney Disease Associate Professor of Medicine, Dept. of Medicine and the School of Epidemiology and Public Health University of Ottawa Scientist, Ottawa Hospital Research Institute  Nephrologist, The Ottawa Hospital Ottawa, Ontario, Canada Dr. Sood[/caption] Manish M Sood MD FRCPC MSc Jindal Research Chair for the Prevention of Kidney Disease Associate Professor of Medicine, Dept. of Medicine and the School of Epidemiology and Public Health University of Ottawa Scientist, Ottawa Hospital Research Institute Nephrologist, The Ottawa Hospital Ottawa, Ontario, Canada  MedicalResearch.com: What is the background for this study? Response: Early work has suggested a very commonly used antibiotic, clarithromycin, may interfere with the metabolism of the most widely used type of blood thinning medication (called direct oral anticoagulants or DOACs) such that the blood level of the DOAC increases and may place the patient at a higher risk for bleeding.  In our study we looked at patients of advanced age (>66 years old) who were given clarithromycin while on a DOAC in Ontario, Canada. We compared patients on clairthromycin-DOAC to patients given a very similar antibiotic, azithromycin, that does not interfere with the metabolism of DOAC.

27 Feb

Posted at 11:30h in Author Interviews, Fertility, Heart Disease, JAMA, OBGYNE
MedicalResearch.com Interview with: Shi Wu Wen PhD Senior Scientist, Clinical Epidemiology Program Professor, Department of Obstetrics & Gynecology University of Ottawa MedicalResearch.com: What is the background for this study? Response: Previous studies have shown that having a baby as a result of using assisted procedures such as IVF nearly doubles the chance that a baby will have heart problems.